title: ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression.
authors: Section of Renal Transplantation/Renovascular Surgery, Department of Urology, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
authors: K
authors: K
authors: Tanabe
authors: T
authors: T
authors: Tokumoto
authors: N
authors: N
authors: Ishikawa
authors: T
authors: T
authors: Shimizu
authors: H
authors: H
authors: Okuda
authors: S
authors: S
authors: Ito
authors: H
authors: H
authors: Shimmura
authors: M
authors: M
authors: Inui
authors: M
authors: M
authors: Harano
authors: M
authors: M
authors: Manu
authors: Y
authors: Y
authors: Shiroyanagi
authors: T
authors: T
authors: Yagisawa
authors: I
authors: I
authors: Nakajima
authors: S
authors: S
authors: Fuchinoue
authors: H
authors: H
authors: Toma
mesh_terms: D000017:ABO Blood-Group System; D000293:Adolescent; D000328:Adult; D001787:Blood Group Incompatibility; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus